Filter Results:
(3,948)
Show Results For
- All HBS Web
(9,191)
- People (36)
- News (2,825)
- Research (3,948)
- Events (29)
- Multimedia (220)
- Faculty Publications (2,404)
Show Results For
- All HBS Web
(9,191)
- People (36)
- News (2,825)
- Research (3,948)
- Events (29)
- Multimedia (220)
- Faculty Publications (2,404)
Sort by
- 02 Aug 2016
- First Look
August 2, 2016
Healthcare Partners Inc. (DaVita), in August 2013. The two would discuss whether Golomb should lead a new DaVita venture, Paladina Health (Paladina), which operated a network of primary care clinics. DaVita had launched Paladina in early... View Details
Keywords: Sean Silverthorne
- 23 May 2011
- Research & Ideas
Corporate Sustainability Reporting: It’s Effective
better have transparency around these issues," he says. "If regulators care about these issues, they should ask companies to disclose their performance around them, and if companies want View Details
Keywords: by Michael Blanding
- 12 Jun 2018
- First Look
New Research and Ideas, June 12, 2018
Protection Regulation, a comprehensive set of consumer data protection laws that would require technology companies to make significant changes to their operating model. Meanwhile, social media giant... View Details
Keywords: Dina Gerdeman
- January 2006 (Revised May 2007)
- Case
Endo Pharmaceuticals (A): From LBO to...?
By: Richard G. Hamermesh and Brian DeLacey
Endo Pharmaceuticals was formed in 1997 as a leveraged buyout spin-off from DuPont Merck. In 1999, it must decide whether to do an IPO or merge with a smaller company. View Details
Keywords: Private Equity; Initial Public Offering; Leveraged Buyouts; Mergers and Acquisitions; Health Care and Treatment; Pharmaceutical Industry; United States
Hamermesh, Richard G., and Brian DeLacey. "Endo Pharmaceuticals (A): From LBO to...?" Harvard Business School Case 806-064, January 2006. (Revised May 2007.)
- Article
Missing the Near Miss: Recognizing Valuable Learning Opportunities in Radiation Oncology
By: Palak Kundu, Olivia Jung, Luca F. Valle, Amy C. Edmondson, Nzhde Agazaryan, John Hegde, Michael Steinberg and Ann Raldow
“Near miss” events are valuable low-cost learning opportunities in radiation oncology as they do not result in patient harm and are more pervasive than adverse events that do. Near misses vary depending on the presence of a latent error of behavior or process, and the... View Details
Kundu, Palak, Olivia Jung, Luca F. Valle, Amy C. Edmondson, Nzhde Agazaryan, John Hegde, Michael Steinberg, and Ann Raldow. "Missing the Near Miss: Recognizing Valuable Learning Opportunities in Radiation Oncology." Practical Radiation Oncology 11, no. 3 (May 2021): e256–e262.
- 27 Jan 2003
- Research & Ideas
New Cluster Mapping Project Helps Companies Locate Facilities
linkages or externalities across industries. Regional economies and clusters are analyzed at various geographic levels including states, economic areas, and metropolitan areas. Access to top-level data on... View Details
Keywords: by Sean Silverthorne
- April 2016 (Revised May 2016)
- Case
Hôpital Universitaire de Mirebalais, Partners In Health in Haiti
By: Robert S. Kaplan, Bipin Mistry and Karla Bertrand
The case describes the application of Time-Driven Activity-Based Costing (TDABC) at a new tertiary hospital, operated by Partners in Health in Mirebelais, Haiti. A project team mapped the clinical processes for use in estimating the direct costs of personnel,... View Details
Keywords: Time-Driven Activity-Based Costing; Activity Based Costing and Management; Cost Accounting; Developing Countries and Economies; Health Care and Treatment; Health Industry; Haiti
Kaplan, Robert S., Bipin Mistry, and Karla Bertrand. "Hôpital Universitaire de Mirebalais, Partners In Health in Haiti." Harvard Business School Case 116-041, April 2016. (Revised May 2016.)
- 30 Jun 2009
- First Look
First Look: June 30
Although China has emerged as one of the fastest growing economies in the world, it still suffers from a weak financial system dominated by state-controlled banks and severely limited access to capital for... View Details
Keywords: Martha Lagace
- 31 Jul 2007
- First Look
First Look: July 31, 2007
Collaborative Management Research, edited by A. B. Shani, N. Adler, N. Mohrman, W. A. Pasmore and B. Stymne. Sage Publications, Inc. 2007 Abstract The gap between theory and practice has been of concern to both practitioners and... View Details
Keywords: Martha Lagace
- 09 Oct 2017
- Research & Ideas
Fearing Fox News, Democratic-leaning Companies Delayed Negative Announcements
information until after the presidential election. The behavior of Democratic-leaning firms in areas with no access to FNC did not change. Non-political firms didn't change their behavior at all, no matter... View Details
- August 2001 (Revised March 2008)
- Case
Helios Health (A)
By: Regina E. Herzlinger and Alfred Martin
Helios PC system provides personalized drug information to the patients in the doctor's waiting room. It has met with considerable consumer acceptance and a very high return for the drug companies that sponsor it. What price should it charge them for the service? View Details
Keywords: Entrepreneurship; Price; Health Care and Treatment; Information Publishing; Innovation and Invention; Product Marketing; Demand and Consumers; Health Industry; Pharmaceutical Industry
Herzlinger, Regina E., and Alfred Martin. "Helios Health (A)." Harvard Business School Case 302-022, August 2001. (Revised March 2008.)
- 2019
- Working Paper
Biometric Monitoring, Service Delivery and Misreporting: Evidence from Healthcare in India
By: Thomas Bossuroy, Clara Delavallade and Vincent Pons
Developing countries increasingly use biometric identification technology in hopes of improving the reliability of administrative information and delivering social services more efficiently. This paper exploits the random placement of biometric tracking devices in... View Details
Keywords: Biometric Technology; Health Care and Treatment; Technological Innovation; Analytics and Data Science; Quality; Performance Improvement; India
Bossuroy, Thomas, Clara Delavallade, and Vincent Pons. "Biometric Monitoring, Service Delivery and Misreporting: Evidence from Healthcare in India." NBER Working Paper Series, No. 26388, October 2019. (Revise and resubmit requested, Review of Economics and Statistics.)
- 06 Jul 2009
- Research & Ideas
Conducting Layoffs: ’Necessary Evils’ at Work
key components for taking care of yourself after performing a necessary evil.” It is important to note, however, that we did not gather data about outcomes in this study, so we cannot conclude that any... View Details
Keywords: by Martha Lagace
- 02 Nov 2020
- What Do You Think?
Is Antitrust Just a Quaint Notion in the Digital Age?
SUMMING UP Is antitrust just a quaint notion in the internet/Cloud age? What do you think? The lack of response to November’s column sends me a message: There appears to be less interest in antitrust issues... View Details
Keywords: by James Heskett; Retail; Technology; Telecommunications; Communications; Consumer Products; Service
- 11 Feb 2002
- Research & Ideas
Guts and Bliss: The Entrepreneur’s Journey
analysis," she advised. Another entrepreneur took a different tack and credited her own decision-making prowess to the power of yoga. Roxanne Quimby, who started Burt's Bees, Inc., a personal care... View Details
Keywords: by Martha Lagace
- 06 Feb 2018
- First Look
First Look at New Research and Ideas: February 6, 2018
at the publicly accessible Harvard Business School online repository titled “Creating Emerging Markets,” we employ our unique methodology to study how environmental factors, such as unexpected market... View Details
- 07 Feb 2017
- First Look
First Look at New Research: February 7
Organization Science Innovation Outcomes in a Distributed Organization: Intra-Firm Mobility and Access to Resources By: Choudhury, Prithwiraj Abstract—Prior research has established a relation between... View Details
Keywords: Sean Silverthorne
- August 2008 (Revised September 2008)
- Supplement
The Flaxil Label (C): Debrief and Endnotes
This case focuses on the 2001 negotiation between Mytex Pharmaceuticals and the U.S. Food and Drug Administration (FDA). The outcome of the negotiation would determine the new label for Mytex's blockbuster drug for arthritis, Flaxil. The negotiation is quite... View Details
Keywords: Safety; Value Creation; Negotiation; Health Care and Treatment; Sales; Pharmaceutical Industry
Barron, Greg M. "The Flaxil Label (C): Debrief and Endnotes." Harvard Business School Supplement 909-003, August 2008. (Revised September 2008.)
- 06 Mar 2006
- What Do You Think?
The China Dilemma for U.S. Firms: Comply, Resist, or Leave?
Gaurav Goel agreed: " . . . the solution is to make sure customers are aware that they are being watched or are being stopped from accessing particular information. Who knows? This may lead View Details
- 27 Feb 2007
- First Look
First Look: February 27, 2007
Working PapersPublic Action for Public Goods Authors:Abhijit Banerjee, Lakshmi Iyer, and Rohini Somanathan Abstract This paper focuses on the relationship between public action and access to public goods.... View Details
Keywords: Martha Lagace